Author: admin

Ujjivan Small Finance Bank is seeking to transition into a universal bank and has applied to the Reserve Bank of India (RBI) for the required license. The bank expects a decision from the RBI by December 2025, as reported by Mint.

In parallel, Ujjivan is planning to raise ₹2,000 crore through a Qualified Institutional Placement (QIP) over the next 18–24 months. According to Business Standard, this capital will support the bank’s ambitious growth targets, including expanding its loan book to ₹1 lakh crore by fiscal year 2030 and increasing its branch network from 752 to 1,150.

The move aligns with RBI’s 2024 guidelines for granting universal banking licenses, which require a minimum net worth of ₹1,000 crore, a profitable track record for the past two years, and at least five years of operations. As reported by Reuters, Ujjivan meets these eligibility criteria and is hopeful for regulatory approval.

If the license is granted, Ujjivan aims to diversify its offerings by expanding into mid-corporate lending and enhancing its deposit base. The bank plans to increase the share of current and savings accounts (CASA) deposits to 35%, according to Business Standard.

This initiative reflects Ujjivan’s strategic approach to strengthening its market position by combining regulatory progress with capital augmentation. With its focus on scaling operations and broadening financial services, Ujjivan is positioning itself to play a significant role in India’s evolving banking landscape.

Shares of Infosys Ltd rose nearly 4% on Tuesday, hitting an intraday high of ₹1,473, ahead of a crucial board meeting scheduled for September 11 to consider a share buyback proposal. Investor sentiment turned positive as buybacks are typically seen as a sign of confidence and a way to return excess cash to shareholders.

If approved, this would be Infosys’ fifth share buyback since 2017. The company last repurchased shares worth ₹9,300 crore in 2022 at ₹1,850 per share. With a strong cash reserve of over ₹23,000 crore, Infosys is well-positioned to execute another sizable buyback.

The board will deliberate on the structure and terms of the buyback, which may be done via a tender offer or open market route. Analysts expect a potential buyback size of ₹9,000–₹12,000 crore, though official details will follow after the meeting.

Infosys shares have fallen nearly 25% over the past year, underperforming the broader market and the Nifty IT index. The anticipated buyback is seen as a strategy to boost earnings per share and stabilize investor confidence, especially amid global IT spending slowdowns.

Despite the recent correction, Infosys reported a 9% YoY rise in net profit and an 8% growth in revenue in the latest quarter, signaling operational resilience.

The buyback news also lifted other IT stocks. The Nifty IT index gained over 1.5%, with peers like TCS, Wipro, and HCL Tech also trading higher.

The outcome of the September 11 board meeting will be closely watched by investors. A generous buyback price could provide further upside for Infosys shares and set the tone for broader IT sector performance in the upcoming earnings season.

In a high-stakes legal face-off, global proprietary trading firm Jane Street began formal proceedings against the Securities and Exchange Board of India (SEBI) at the Securities Appellate Tribunal (SAT) today. The firm is contesting SEBI’s July 2025 interim order that accuses it of manipulating India’s derivatives markets and freezes nearly ₹4,843 crore in alleged unlawful gains.

The SAT bench, led by Justice P.S. Dinesh Kumar, commenced hearing Jane Street’s appeal, where the firm strongly denied any wrongdoing and sought a stay on SEBI’s restrictions. Jane Street argued that SEBI’s action lacked procedural fairness, pointing to the regulator’s refusal to share internal communications and whistleblower reports key to its defense.

SEBI’s interim order claimed that Jane Street employed manipulative trading strategies, particularly on expiry days of Nifty and Bank Nifty index options, executing aggressive trades in the morning to influence market prices. These trades allegedly helped the firm amass extraordinary profits in index options, ₹43,289 crore over 27 months, while other trading segments showed losses.

SEBI barred Jane Street and its Indian affiliates from trading in Indian securities and froze their profits, stating that the strategies were “prima facie manipulative.”

Jane Street, known globally for quantitative trading, contends that its actions constituted routine arbitrage, legal and widely practiced across markets. It maintains that SEBI has denied it access to crucial documents, including exchanges between SEBI and the whistleblower Mayank Bansal, as well as correspondence with the National Stock Exchange (NSE).

“The lack of transparency has compromised our right to a fair hearing,” said Jane Street’s legal team in court, emphasizing that the firm paid the escrow amount under protest but remains unable to resume operations in India.

Sources close to the investigation revealed that SEBI initially considered closing the case but escalated the probe in late 2024 due to continued complaints and insufficient data from Jane Street. The crackdown is now seen as a watershed moment in India’s regulatory oversight of high-frequency and algorithmic trading.

The case is being closely watched by global trading giants, including Citadel, Jump Trading, and IMC, many of which operate in Indian markets. Legal experts say the outcome could set a precedent for how India handles market manipulation claims involving sophisticated foreign players.

As hearings continue, the tribunal is expected to rule on Jane Street’s plea to suspend SEBI’s trading ban and order full disclosure of withheld documents. A final decision could significantly impact regulatory frameworks surrounding derivatives trading and transparency in enforcement proceedings.

Amanta Healthcare Limited made a strong debut on the Indian stock exchanges today, with its shares listing at a premium over the issue price. The stock opened at ₹135 on the National Stock Exchange (NSE), marking a 7.14% gain from the issue price of ₹126 per share. On the Bombay Stock Exchange (BSE), shares debuted at ₹134.90, reflecting a 6.35% premium.

The listing aligns with market expectations, as indicated by the grey market premium (GMP) of ₹9 per share prior to the debut, suggesting a listing price of around ₹135.

IPO Subscription and Allotment Details

The Initial Public Offering (IPO) of Amanta Healthcare was open for subscription from September 1 to September 3, 2025, and was oversubscribed by 82.61 times, according to data from the National Stock Exchange. The retail category was subscribed 54.98 times, while the Non-Institutional Investors (NIIs) segment saw a subscription of 209.42 times. Qualified Institutional Buyers (QIBs) subscribed 35.86 times, indicating strong investor interest across all categories.

The IPO comprised a fresh issue of 1 crore equity shares, raising ₹126 crore for the company. The allotment was finalized on September 4, with shares credited to demat accounts on September 9, coinciding with the listing date.

Use of IPO Proceeds

Amanta Healthcare plans to utilize the proceeds from the IPO to fund capital expenditure for expanding its manufacturing capabilities. Approximately ₹70 crore will be allocated to set up a new SteriPort manufacturing line at the company's Hariyala, Kheda facility in Gujarat, expected to commence operations by January 2026. An additional ₹30.13 crore will be used to develop a new Small Volume Parenteral (SVP) manufacturing line at the same facility, targeted for completion by January 2027. The remaining funds will support general corporate purposes.

Company Overview

Established in December 1994, Amanta Healthcare is a leading pharmaceutical company specializing in sterile liquid products. The company's product portfolio includes intravenous fluids, ophthalmic solutions, respiratory care products, and irrigation solutions. Amanta Healthcare employs advanced technologies such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) in its manufacturing processes, ensuring high-quality standards in its offerings.

Urban Company’s much-anticipated IPO is creating quite a buzz. Scheduled to open from September 10 to 12, the company aims to raise ₹1,900 crore, with shares priced between ₹98 and ₹103 each. But it’s the surge in Grey Market Premium (GMP),  jumping nearly 30% in just six days,  that’s grabbing investors’ attention.

A GMP of ₹28 over the IPO price suggests a potential listing gain of around 27%, reflecting strong enthusiasm in the market. However, experts are urging investors to look beyond the hype. The GMP is an unofficial figure and can be unpredictable, so it shouldn’t be the only factor guiding investment decisions.

Urban Company, founded in 2014 and based in Gurugram, operates in 51 cities across India, the UAE, and Singapore. It offers a variety of services, from home cleaning and pest control to plumbing, electrical work, beauty treatments, and appliance repairs. The company plans to use the funds raised to improve its technology, expand infrastructure, pay office leases, and boost marketing efforts.

Despite the excitement, some red flags remain. The company’s revenues have grown steadily, from ₹828 crore in FY24 to ₹1,144 crore in FY25, but profitability has been uneven. While it recorded a net profit of ₹27 crore over the first nine months of FY25, profits slipped sharply in the first quarter of FY26. Past years have also seen net losses and negative cash flows, raising questions about long-term sustainability.

“Urban Company’s growth story is impressive, but maintaining profitability will be key,” says a market analyst. “Investors should carefully weigh the risks and not get swept up in the hype.”

The IPO will open for subscription on September 10 and close on September 12, with anchor investors able to bid starting September 9. Retail investors can apply for a minimum of 145 shares, meaning an investment of roughly ₹14,210 at the lower end of the price band. Final allotments are expected by September 15, and the shares are slated to debut on the stock exchange on September 17.

As Urban Company approaches its market debut, investors are advised to balance optimism with due diligence, carefully evaluating the company’s financial strength and long-term prospects before making investment decisions.

Apple is currently embroiled in a class-action copyright lawsuit filed by authors Grady Hendrix and Jennifer Roberson. The suit alleges that Apple used their copyrighted books without permission to train its artificial intelligence systems, including the OpenELM language model, which is part of the company’s Apple Intelligence AI initiative.

The authors claim Apple incorporated their protected works into a dataset of pirated books without obtaining consent, providing credit, or offering any form of compensation. They argue that despite the commercial potential of Apple’s AI technology, the company failed to seek authorization or pay them for the use of their creative content.

This lawsuit is part of a growing wave of legal challenges targeting major technology companies accused of using copyrighted materials to train AI systems without permission. Similar cases have been brought against Microsoft, Meta Platforms, and OpenAI. Notably, Anthropic, another AI developer, recently settled a class-action lawsuit for at least $1.5 billion after being found to have stored millions of pirated books, though a judge had ruled its initial use of copyrighted works was “fair use.”

The outcome of Apple’s case could have far-reaching consequences for the AI industry. It raises pressing questions about how AI companies access, utilize, and compensate for copyrighted works in their training datasets. Authors and publishers continue to express growing concerns about the unauthorized use of their creative works in AI development, seeking clearer legal protections and fair remuneration.

Hero MotoCorp has announced the appointment of Harshavardhan Chitale as its new Chief Executive Officer, effective January 5, 2026. Chitale will succeed Vikram Kasbekar, who has been serving as acting CEO since May 2025, following the resignation of Niranjan Gupta. Kasbekar will continue with the company as Executive Director and Chief Technology Officer.

Chitale brings over 30 years of global leadership experience to Hero MotoCorp. He most recently served as Global CEO of Signify’s Professional Business, overseeing 12,000 employees across 70 countries. During his tenure, the business doubled its profitability and launched over 100 new products annually, including IoT-enabled lighting solutions. Before that, Chitale was Vice Chairman and Managing Director of Philips Lighting India, where he successfully led the company’s spin-off into a standalone public entity and strengthened its market leadership. He has also held key leadership roles at HCL Infosystems and Honeywell Automation India.

Commenting on the appointment, Hero MotoCorp Executive Chairman Pawan Munjal said, “Harsh’s outstanding track record in driving growth, fostering innovation, and leading global transformation makes him the ideal leader for Hero MotoCorp at this pivotal moment. His vision and dynamism will accelerate our journey across electric and emerging mobility, premiumization, digitalisation, sustainability, and organisational renewal — shaping the future of mobility and beyond.”

Munjal further noted in a press release that Mr. Chitale’s appointment will accelerate the ‘Splendor’ motorcycle maker’s push into electric and emerging mobility.

The leadership change comes as Hero MotoCorp undergoes strategic transformations, including the planned spin-off of its Electric Vehicle and Emerging Mobility Business Unit into an independent entity starting February 2025. The company is also intensifying its focus on expanding its electric vehicle footprint and enhancing its digital capabilities.

Chitale’s vast expertise in driving global business transformation and fostering innovation is poised to play a crucial role in shaping Hero MotoCorp’s path toward sustained growth and industry leadership.

In a decisive move to cement Bengaluru’s position as a global technology powerhouse, the Karnataka government has approved 6.17 acres of land in Hesaraghatta for the creation of Quantum City (Q‑City) — India’s first dedicated hub for quantum science and innovation. Touted as a game-changer for the country’s tech landscape, the project aims to place India at the forefront of the quantum revolution.

Announced by Science and Technology Minister N. S. Boseraju, the initiative is part of Karnataka’s broader goal to build a $20 billion quantum economy by 2035. The land sanction fulfills a commitment made during the Quantum India Bengaluru Conclave, held earlier this year, where the state unveiled its strategic vision to lead the country in quantum science.

Quantum City is envisioned as a cutting-edge ecosystem bringing together research institutions, startups, and industry leaders. The proposed campus will feature advanced quantum labs, start-up incubation centres, quantum hardware production units, and high-performance computing infrastructure. The goal is to create a platform that supports both fundamental research and real-world applications across computing, cryptography, and secure communication.

Alongside this, the government has also sanctioned 8 acres of land for the expansion of the International Centre for Theoretical Sciences (ICTS–TIFR), reinforcing its commitment to strengthening theoretical research and academic excellence.

Minister Boseraju described the project as a “historic milestone” for the state. “Quantum City will make Karnataka a global destination for quantum innovation. It will attract international talent, foster deep tech start-ups, and reinforce Bengaluru’s status as India’s technology capital,” he said.

The project is expected to accelerate India’s capabilities in emerging technologies and create a strong pipeline of quantum talent through academic-industry partnerships. Further details, including development timelines and collaborations, are expected to be announced in the coming months.

As global interest in quantum technologies intensifies, Karnataka’s Quantum City stands as a bold and strategic step toward securing India’s place in the future of science and innovation.

In a significant shift signaling its evolution from a single brand into a global hospitality powerhouse, OYO has renamed its parent company from Oravel Stays Limited to PRISM. This rebranding comes as the company gears up for its upcoming initial public offering (IPO) and aims to broaden its presence across a wide range of travel, accommodation, and lifestyle segments worldwide.

Founder and CEO Ritesh Agarwal explained that PRISM reflects the company’s broad portfolio of brands and services, which now includes everything from budget hotels and vacation homes to workspaces and event planning. He emphasised, “PRISM creates a future-ready corporate structure that brings all our businesses under one roof while keeping their unique identities intact.

While PRISM will serve as the corporate umbrella, OYO itself remains the well-known name for travelers seeking affordable, reliable accommodations worldwide. Alongside OYO, the group includes brands like Motel 6, Studio 6, Belvilla, Innov8, and Weddingz. in, each catering to different customer needs and markets.

The name PRISM was chosen after a global contest, attracting thousands of suggestions from employees and partners. It symbolizes the company’s multifaceted approach to travel and hospitality, offering a spectrum of experiences to millions of customers across more than 35 countries.

As Agarwal put it, “This is an exciting new chapter for us, a chance to build a stronger, more diversified company that’s ready for the future of travel.”

Since launching in 2012, OYO has grown rapidly, serving over 100 million customers globally. The rebrand to PRISM is not just about a name change; it marks a strategic shift to support profitable growth, invest in cutting-edge technology, and prepare for the company’s upcoming IPO.